Intravenous Regional Anesthesia.
Conditions
Interventions
Intervention 1: Control: 3 mg/kg Lidocaine (max: 200mg). Intervention 2: Intervention 1: 3mg/kg Lidocaine (max: 200mg)+ 200 microgram TNG. Intervention 3: Intervention 2: 3 mg/kg Lidocaine (max: 20
Treatment - Drugs
Control: 3 mg/kg Lidocaine (max: 200mg)
Intervention 1: 3mg/kg Lidocaine (max: 200mg)+ 200 microgram TNG
Intervention 2: 3 mg/kg Lidocaine (max: 200mg)+ 8 mg Dexamethasone
Sponsors
Urmia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 49 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: male or female patients; scheduled for hand or forearm surgery with I & II physical status of ASA; aged between 20 and 50 years. Exclusion criteria: Patients with sickle cell anemia; Raynaud's disease; history of drug allergy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The onset time of sensory block. Timepoint: every 30 sec. Method of measurement: Pinprick test.;The onset time of motor block. Timepoint: every minute. Method of measurement: ability to flex and exten wriet and fingures.;The onset time of tourniquet pain. Timepoint: in 1, 5, 10, 20, and 30 minutes. Method of measurement: visual analog scale of pain.;The recovery time from sensory block. Timepoint: every 30 sec. Method of measurement: Pinprick test.;The recovery time from motor block. Timepoint: in 1, 5, 10, 20, and 30 minutes. Method of measurement: ability to flex and exten wriet and fingures. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of analgesic consumptions. Timepoint: If patient reported VAS>3. Method of measurement: 1 micro gr/kg. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ebrahim Hassani
Urmia university of Medical Sciences
Outcome results
None listed